Zobrazeno 1 - 5
of 5
pro vyhledávání: '"de Boo LW"'
Autor:
de Boo LW; Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands., Jóźwiak K; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany., Ter Hoeve ND; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Opdam M; Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands., Wang Y; Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands., Schmidt MK; Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Clinical Genetics, Leiden University Medical Centre, Leiden, The Netherlands., de Jong V; Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands., Kleiterp S; Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands., Cornelissen S; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterdam, The Netherlands., Baars D; Department of Biometrics, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Koornstra RHT; Department of Medical Oncology, Rijnstate Medical center, Arnhem, The Netherlands., Kerver ED; Department of Medical Oncology, OLVG, Amsterdam, The Netherlands., van Dalen T; Department of Surgery, Diakonessenhuis Utrecht, Utrecht, The Netherlands., Bins AD; Department of Medical Oncology, Amsterdam UMC, Amsterdam, The Netherlands., Beeker A; Department of Medical Oncology, Spaarne Gasthuis, Hoofddorp, The Netherlands., van den Heiligenberg SM; Department of Medical Oncology, Dijklander Ziekenhuis, Hoorn, The Netherlands., de Jong PC; Department of Medical Oncology, Sint Antonius Hospital, Utrecht, The Netherlands., Bakker SD; Department of Internal Medicine, Zaans Medical Centre, Zaandam, The Netherlands., Rietbroek RC; Department of Medical Oncology, Rode Kruis Hospital, Beverwijk, The Netherlands., Konings IR; Department of Medical Oncology, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam, The Netherlands., Blankenburgh R; Department of Medical Oncology, Saxenburgh Medical Center, Hardenberg, The Netherlands., Bijlsma RM; Department of Medical Oncology, UMC Utrecht Cancer Center, Utrecht, The Netherlands., Imholz ALT; Department of Internal Medicine, Deventer Hospital, Deventer, The Netherlands., Stathonikos N; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Vreuls W; Department of Pathology, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands., Sanders J; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Rosenberg EH; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Koop EA; Department of Pathology, Gelre Ziekenhuizen, Apeldoorn, The Netherlands., Varga Z; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland., van Deurzen CHM; Department of Pathology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., Mooyaart AL; Department of Pathology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands., Córdoba A; Department of Pathology, Complejo Hospitalaria de Navarra, Pamplona, Spain., Groen E; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Bart J; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands., Willems SM; Department of Pathology and Medical Biology, University Medical Center Groningen, Groningen, The Netherlands., Zolota V; Department of Pathology, Rion University Hospital, Patras, Greece., Wesseling J; Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Sapino A; Department of Medical Sciences, University of Torino, Torino, Italy; Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Chmielik E; Tumor Pathology Department, Maria Sklodowska-Curie Memorial National Research Institute of Oncology, Gliwice, Poland., Ryska A; Charles University Medical Faculty and University Hospital, Hradec Kralove, Czech Republic., Broeks A; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterdam, The Netherlands., Voogd AC; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands., van der Wall E; Cancer Center, University Medical Center Utrecht, Utrecht, The Netherlands., Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands., Salgado R; Division of Clinical Medicine and Research, Peter MacCallum Cancer Centre, Melbourne, Australia; Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium., Dackus GMHE; Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Hauptmann M; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany., Kok M; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Tumorbiology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Linn SC; Department of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: s.linn@nki.nl.
Publikováno v:
ESMO open [ESMO Open] 2024 Mar; Vol. 9 (3), pp. 102923. Date of Electronic Publication: 2024 Mar 06.
Autor:
Wang Y; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Dackus GMHE; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Rosenberg EH; Division of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Cornelissen S; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterdam, The Netherlands., de Boo LW; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Broeks A; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterdam, The Netherlands., Brugman W; Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands., Chan TWS; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., van Diest PJ; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Hauptmann M; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany., Ter Hoeve ND; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands., Isaeva OI; Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands., de Jong VMT; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Jóźwiak K; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany., Kluin RJC; Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands., Kok M; Division of Tumor Biology and Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Koop E; Department of Pathology, Gelre Ziekenhuizen, Apeldoorn, The Netherlands., Nederlof PM; Division of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Opdam M; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Schouten PC; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, The Netherlands.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands., van Steenis C; Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands., Voogd AC; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands., Vreuls W; Department of Pathology, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands., Salgado RF; Department of Pathology, GZA-ZNA Hospitals, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Center, Melbourne, Australia., Linn SC; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, The Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Schmidt MK; Division of Molecular Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. mk.schmidt@nki.nl.; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands. mk.schmidt@nki.nl.
Publikováno v:
BMC medicine [BMC Med] 2024 Jan 09; Vol. 22 (1), pp. 9. Date of Electronic Publication: 2024 Jan 09.
Autor:
de Boo LW; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Jóźwiak K; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.; Department of Epidemiology and Biostatistics, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Joensuu H; Department of Oncology, Helsinki University Hospital and University of Helsinki, Helsinki, Finland., Lindman H; Department of Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden., Lauttia S; Laboratory of Molecular Oncology, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland., Opdam M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Steenis C; Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Brugman W; Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Kluin RJC; Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schouten PC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Kok M; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Nederlof PM; Department of Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Hauptmann M; Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.; Department of Epidemiology and Biostatistics, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Linn SC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. s.linn@nki.nl.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. s.linn@nki.nl.; Department of Pathology, University Medical Centre, Utrecht, The Netherlands. s.linn@nki.nl.
Publikováno v:
British journal of cancer [Br J Cancer] 2022 Jun; Vol. 126 (10), pp. 1401-1409. Date of Electronic Publication: 2022 Feb 05.
Autor:
Ros S; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge, UK. Electronic address: susana.ros@cruk.cam.ac.uk., Wright AJ; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge, UK., D'Santos P; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge, UK., Hu DE; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge, UK., Hesketh RL; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge, UK., Lubling Y; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge, UK., Georgopoulou D; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge, UK., Lerda G; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge, UK., Couturier DL; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK., Razavi P; Human Oncology and Pathogenesis Program, X and Department of Pathology, Y and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Pelossof R; Human Oncology and Pathogenesis Program, X and Department of Pathology, Y and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Batra AS; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge, UK., Mannion E; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge, UK., Lewis DY; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge, UK., Martin A; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge, UK., Baird RD; Breast Cancer Research Programme, Cancer Research UK Cambridge Centre, Cambridge, UK., Oliveira M; Medical Oncology, Vall d'Hebron Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., de Boo LW; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Linn SC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Scaltriti M; Human Oncology and Pathogenesis Program, X and Department of Pathology, Y and Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rueda OM; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge, UK., Bruna A; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge, UK., Caldas C; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge, UK., Brindle KM; Cancer Research UK Cambridge Institute and Department of Oncology, Li Ka Shing Centre, University of Cambridge, Cambridge, UK; Cancer Research UK Cambridge Cancer Centre, Cambridge, UK; Department of Biochemistry, University of Cambridge, Cambridge UK. Electronic address: kmb1001@cam.ac.uk.
Publikováno v:
Cancer cell [Cancer Cell] 2020 Oct 12; Vol. 38 (4), pp. 516-533.e9. Date of Electronic Publication: 2020 Sep 24.
Autor:
de Boo LW; Department of Internal Medicine, Reinier de Graaf Hospital, 2625AD Delft, The Netherlands., Vulink AJE; Division of Medical Oncology, Reinier de Graaf Hospital, 2625AD Delft, The Netherlands., Bos MEMM; Department of Medical Oncology, Erasmus Medical Center, 3015 CE Rotterdam, The Netherlands.
Publikováno v:
Molecular and clinical oncology [Mol Clin Oncol] 2017 Dec; Vol. 7 (6), pp. 1130-1134. Date of Electronic Publication: 2017 Oct 18.